Research and Markets has announced the addition of the "Global Urticaria Epidemiology and Patient Flow Analysis - 2017" report to their offering.

The results of the Urticaria patients study are announced in this new report Global Urticaria Epidemiology and Patient Flow Analysis - 2017'. The report provides insights into Urticaria epidemiology, Urticaria diagnosed patients, and Urticaria treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Urticaria derived from epidemiological analysis, percentage of patients diagnosed with Urticaria, and percentage of patients treated with a therapy.

The study helps executives estimate Urticaria market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Urticaria prevalence, Urticaria diagnosis rate, and Urticaria treatment rate for the period 2016 - 2025. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:

  • Urticaria Patient Flow
  • Urticaria Prevalence
  • Urticaria Diagnosed Patients
  • Urticaria Treated Patients

Key Topics Covered:

1. Urticaria: Disease Definition

2. Global Urticaria Patient Flow

3. Urticaria Patient Flow in the US

4. Urticaria Patient Flow in Europe

5. Urticaria Patient Flow in Germany

6. Urticaria Patient Flow in France

7. Urticaria Patient Flow in Spain

8. Urticaria Patient Flow in Italy

9. Urticaria Patient Flow in UK

10. Urticaria Patient Flow in Japan

11. Research Methodology

For more information about this report visit http://www.researchandmarkets.com/research/www4tz/global_urticaria

Research and MarketsLaura Wood, Senior Managerpress@researchandmarkets.comFor E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716Related Topics: Dermatological Drugs